Barrington analyst Gary Prestopino lowered the firm’s price target on Dorman Products to $127 from $130 and keeps an Outperform rating on the shares following quarterly results. The firm notes net sales were in line with expectations as net sales growth progressed on a monthly basis throughout Q1/2023, while EPS were in line with management’s expectations excluding the impact of approximately $4M of charges booked into SG&A expense. As expected, inflated cost inventory depressed gross margin, with management saying it believes the "high-water mark" in terms of inflated cost inventory is behind the company as inventory balances dropped to $687M at the end of Q1/2023 from $756M at the end of Q4/2022. Starting in Q2/2023, Dorman expects to see lower cost inventory selling through, driving sequential margin expansion, the firm adds.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on DORM:
- Dorman Products sees FY23 adjusted EPS $5.15-$5.35, consensus $5.20
- Dorman Products, Inc. Reports First Quarter 2023 Results
- Dorman Products reports Q1 adjusted EPS 56c, consensus 94c
- DORM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Dorman Products, Inc. Announces Date to Report First Quarter 2023 Financial Results